Susquehanna Fundamental Investments, LLC Summit Therapeutics Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 67,378 shares of SMMT stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
67,378
Previous 48,877
37.85%
Holding current value
$1.24 Million
Previous $202 Million
159.72%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding SMMT
# of Institutions
192Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$448 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$145 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$99.8 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$63.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.69B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...